BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Roche (RHHBY) Looks to Replicate Cancer Success With Eye Drugs


8/28/2013 7:33:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Positive results for Roche's experimental eye drug should bolster its position in the multibillion-dollar-a-year market for vision loss treatments, as it looks to branch out beyond its core cancer expertise. After scrapping drugs to treat diabetes and boost levels of "good" high-density cholesterol, the world's largest maker of cancer drugs is hoping to prove it has a stronger hand when it comes to developing treatments for the eyes. The company has already chalked up one success with Lucentis, a treatment for wet age-related macula degeneration (AMD), which had sales of $1.5 billion in the United States last year.

Help employers find you! Check out all the jobs and post your resume.


Read at Reuters

Reuters
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES